Next Article in Journal
Rigosertib-Activated JNK1/2 Eliminate Tumor Cells through p66Shc Activation
Next Article in Special Issue
Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents
Previous Article in Journal
Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France
Previous Article in Special Issue
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 13 May 2020 16:50 CEST Original file -
article pdf uploaded. 13 May 2020 16:50 CEST Version of Record https://www.mdpi.com/2079-7737/9/5/98/pdf-vor
article xml file uploaded 28 May 2020 11:09 CEST Update -
article xml uploaded. 28 May 2020 11:09 CEST Update https://www.mdpi.com/2079-7737/9/5/98/xml
article pdf uploaded. 28 May 2020 11:09 CEST Updated version of record https://www.mdpi.com/2079-7737/9/5/98/pdf
article html file updated 28 May 2020 11:17 CEST Original file -
article html file updated 21 July 2022 04:45 CEST Update https://www.mdpi.com/2079-7737/9/5/98/html
Back to TopTop